178 related articles for article (PubMed ID: 19228479)
21. An assessment of the carcinogenic potential of ezetimibe using nonclinical data in a weight-of-evidence approach.
Halleck M; Davis HR; Kirschmeier P; Levitan D; Snyder RD; Treinen K; Macdonald JS
Toxicology; 2009 Apr; 258(2-3):116-30. PubMed ID: 19428931
[TBL] [Abstract][Full Text] [Related]
22. Ezetimibe--an update.
Drug Ther Bull; 2009 Aug; 47(8):91-5. PubMed ID: 19654419
[TBL] [Abstract][Full Text] [Related]
23. Management of mixed hyperlipidaemia.
Stalenhoef AF
Eur Heart J; 2005 May; 26(9):856-7. PubMed ID: 15781431
[No Abstract] [Full Text] [Related]
24. Ezetimibe and cancer--an uncertain association.
Drazen JM; D'Agostino RB; Ware JH; Morrissey S; Curfman GD
N Engl J Med; 2008 Sep; 359(13):1398-9. PubMed ID: 18765434
[No Abstract] [Full Text] [Related]
25. Clinical experience with ezetimibe/simvastatin in a Mediterranean population.
Migdalis I; Efthimiadis A; Pappas S; Alexopoulos D; Vlasserou F; Mikhailidis DP
Curr Med Res Opin; 2009 Oct; 25(10):2571-6. PubMed ID: 19739939
[TBL] [Abstract][Full Text] [Related]
26. Assessing Optimal Blood Pressure in Patients With Asymptomatic Aortic Valve Stenosis: The Simvastatin Ezetimibe in Aortic Stenosis Study (SEAS).
Nielsen OW; Sajadieh A; Sabbah M; Greve AM; Olsen MH; Boman K; Nienaber CA; Kesäniemi YA; Pedersen TR; Willenheimer R; Wachtell K
Circulation; 2016 Aug; 134(6):455-68. PubMed ID: 27486164
[TBL] [Abstract][Full Text] [Related]
27. Ezetimibe-Simvastatin, a pharmacodynamic interaction?
Lozano R; Marin R; Santacruz MJ; Freire I
Expert Opin Pharmacother; 2013 Feb; 14(3):359-60. PubMed ID: 23346887
[No Abstract] [Full Text] [Related]
28. Ezetimibe revisited.
Med Lett Drugs Ther; 2008 Aug; 50(1293):67-8. PubMed ID: 18719525
[No Abstract] [Full Text] [Related]
29. Clinical inquiries. What are effective medication combinations for dyslipidemia?
Saseen J; Tweed E; Crawford P
J Fam Pract; 2006 Jan; 55(1):70-2. PubMed ID: 16388773
[No Abstract] [Full Text] [Related]
30. The IMPROVE-IT study and ezetimibe.
Signy J; Signy M
Br J Community Nurs; 2015 May; 20(5):243-4. PubMed ID: 25993373
[No Abstract] [Full Text] [Related]
31. Zetia and Zocor: good together? New combo pill Vytorin may help some reach low LDL goals.
Harv Health Lett; 2005 Feb; 30(4):3. PubMed ID: 15776505
[No Abstract] [Full Text] [Related]
32. Adherence to single-pill combination versus multiple-pill combination lipid-modifying therapy among patients with mixed dyslipidemia in a managed care population.
Kamat SA; Bullano MF; Chang CL; Gandhi SK; Cziraky MJ
Curr Med Res Opin; 2011 May; 27(5):961-8. PubMed ID: 21381893
[TBL] [Abstract][Full Text] [Related]
33. [When should an association of lipid-lowering drugs be proposed in a patient failing to reach therapeutic targets under monotherapy? Guidelines of the New French Society of Atherosclerosis].
Farnier M; Bonnet F; Bruckert E; Ferrières J; Paillard F;
Arch Mal Coeur Vaiss; 2007; 100(6-7):569-81. PubMed ID: 17893640
[No Abstract] [Full Text] [Related]
34. Comment on: Clinical benefits of ezetimibe: absence of proof is just that.
Doggrell SA
Expert Opin Pharmacother; 2013 Dec; 14(18):2611-2. PubMed ID: 24160556
[No Abstract] [Full Text] [Related]
35. Letter to the Editor: The ezetimibe 'controversy' is a misunderstanding.
Spence JD
Expert Opin Pharmacother; 2012 Dec; 13(17):2579-80; author reply 2580. PubMed ID: 22998481
[No Abstract] [Full Text] [Related]
36. [Heart Protection Study].
Larsen ML; Hildebrandt PR
Ugeskr Laeger; 2002 Jan; 164(3):348. PubMed ID: 11816337
[No Abstract] [Full Text] [Related]
37. Clinical benefits of ezetimibe use: is absence of proof, proof of absence?
Gouni-Berthold I; Mikhailidis DP; Rizzo M
Expert Opin Pharmacother; 2012 Oct; 13(14):1985-8. PubMed ID: 22946714
[No Abstract] [Full Text] [Related]
38. [Lower is better: ENHANCE affair].
Scardi S; Umari P; D'Agata BM
Monaldi Arch Chest Dis; 2008 Jun; 70(2):47-50. PubMed ID: 18754270
[TBL] [Abstract][Full Text] [Related]
39. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
[No Abstract] [Full Text] [Related]
40. [An extensive English study: reduced cardiovascular mortality and morbidity by statin].
Nilsson P; Erhardt L
Lakartidningen; 2001 Dec; 98(51-52):5846-50. PubMed ID: 11806257
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
